Key TakeawaysGLOBE and GUARD link Medicare drug rebates to international pricing, potentially saving billions but not benefiting health plans or patients directly.The programs affect only 25% of claims, with single-source drugs or biologics included, and face uncertainties in international price calculations.Legal challenges may arise due to potential overreach of CMMI’s authority and the complexity of […]
